Table 2

Procedure outcomes

TotalRVOT stenting or prestenting (before TPVR)Aortic coarctation stentingFontan-circulation fenestration closureMiscellaneous
Patients, n (%)N=170106 (62.4)26 (15.3)21 (12.4)17 (10)
Implantation success, n (%)168 (98.9)104 (98.1)26 (100)21 (100)17 (100)
Unplanned (non-emergent) open-heart surgeries, n (%)2 (1.2)2 (1.9)
Serious procedural complications, n (%)4 (2.4)3 (2.8)1 (3.8)
Stent slipping down during uncovering/off target implantation/elective surgical revalvulation1 (0.6)1 (0.9)
Brain stroke*1 (0.6)1 (3.8)
Life-threatening wire-related haemoptysis†2 (1.2)2 (1.9)
Minor procedural complications, n (%)21 (12.4)15 (14.1)1 (3.8)2 (9.5)3 (17.7)
Uncomplicated delivery balloon rupture3 (1.8)‡3 (2.8)
Stent slipping down the carrier during delivery5 (2.9)3 (2.8)2 (9.5)
Controlled stent migration during implantation5 (2.9)3 (2.8)2 (11.8)
Contained vascular rupture2 (1.2)2 (1.9)
Bleeding requiring transfusion1 (0.6)1 (0.9)
Minor wire-related haemoptysis3 (1.8)2 (1.9)1 (5.9)
Transient rhythm disturbances2 (1.2)1 (0.9)1 (3.8)
Vascular access complications, n (%)6 (3.5)4 (3.8)2 (9.5)
Uncomplicated groin haematoma2 (1.2)1 (0.9)1 (4.8)
Surgically treated arteriovenous fistula2 (1.2)2 (1.9)
Self-resolving arteriovenous fistula1 (0.6)1 (4.8)
Left femoral artery pseudoaneurysm1 (0.6)1 (0.9)
Total hospital stay (days), median (IQR)2 (2–3)2 (2–3)2 (2–3)2 (2–2)2 (2–3)
Follow-up (months), median (IQR)9 (4–14)12 (5–16)9 (3–13)5 (3–10)7 (4–12)
In-hospital death, n (%)1 (0.6)1 (0.9)
  • *Treated with thrombolysis and thrombectomy.

  • †Severe wire-related haemoptysis secondary to stent slippage during delivery and excessive manipulations led in one patient to abortion of the prestenting procedure and elective surgical revalvulation.

  • ‡Two were secondary to exposed fragments of previously implanted fractured stents within the target zone.

  • RVOT, right ventricular outflow tract; TPVR, transcatheter pulmonary valve replacement.